CD83 and rheumatoid arthritis: Furthermore, treatment of immature DCs with EMVs derived from plasma of patients with RA resulted in DC maturation, as evidenced by increased expression of CD83 and CD86 (as MFI; Figures 2A, B) respect to both HD EMV treated-DCs and untreated DCs.